Wednesday, 14 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 28, 2026

Samoan Community Leaders, Environmental Advocates Call on Coca-Cola’s Largest Bottler to Keep Plastic out of the Pacific and Bring Back Reusable Packaging

View original at finance.yahoo.com
Samoan Community Leaders, Environmental Advocates Call on Coca-Cola’s Largest Bottler to Keep Plastic out of the Pacific and Bring Back Reusable Packaging Oceana, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Due to limited recycling capacity in Samoa, most plastic waste ends up littered, illegally dumped, incinerated, or landfilled, with consequences visible on land, beaches, and in the water.

    60% confidence

  • Coca-Cola should move back to reusable bottles like glass in Samoa and become a leader in the transition away from plastics.

    60% confidence

  • CCEP is Coca-Cola's largest bottler by revenue and operates across 31 global markets including Western Europe, Indonesia, the Philippines, Australia, New Zealand, and the Pacific Islands.

    60% confidence

  • In 2021, Coca-Cola stopped bottling its products in reusable glass bottles in Samoa and now imports large quantities of single-use plastic bottles from Fiji and New Zealand.

    60% confidence

  • Imports of plastic bottles to Samoa more than doubled between 2020 and 2025, and Coca-Cola products account for about one-third of beverage bottle waste in the country.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Samoan Community Leaders, Environmental Advocates Call on Coca-Cola’s Largest Bottler to Keep Plastic out of the Pacific and Bring Back Reusable Packaging — Source | Via News | ViaNews EU